These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


752 related items for PubMed ID: 16499586

  • 1. Hepatocellular carcinoma in children and effect of living-donor liver transplantation on outcome.
    Arikan C, Kilic M, Nart D, Ozgenc F, Ozkan T, Tokat Y, Yagci RV, Aydogdu S.
    Pediatr Transplant; 2006 Feb; 10(1):42-7. PubMed ID: 16499586
    [Abstract] [Full Text] [Related]

  • 2. Selection criteria for liver transplantation in early-stage hepatocellular carcinoma with cirrhosis: results of a multicenter study.
    Figueras J, Ibañez L, Ramos E, Jaurrieta E, Ortiz-de-Urbina J, Pardo F, Mir J, Loinaz C, Herrera L, López-Cillero P, Santoyo J.
    Liver Transpl; 2001 Oct; 7(10):877-83. PubMed ID: 11679986
    [Abstract] [Full Text] [Related]

  • 3. Comparison of clinical outcomes in chronic hepatitis B liver transplant candidates with and without hepatocellular carcinoma.
    Wong SN, Reddy KR, Keeffe EB, Han SH, Gaglio PJ, Perrillo RP, Tran TT, Pruett TL, Lok AS.
    Liver Transpl; 2007 Mar; 13(3):334-42. PubMed ID: 17154401
    [Abstract] [Full Text] [Related]

  • 4. Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: a comparative study.
    Figueras J, Jaurrieta E, Valls C, Benasco C, Rafecas A, Xiol X, Fabregat J, Casanovas T, Torras J, Baliellas C, Ibañez L, Moreno P, Casais L.
    Hepatology; 1997 Jun; 25(6):1485-9. PubMed ID: 9185772
    [Abstract] [Full Text] [Related]

  • 5. Liver transplantation for childhood hepatic malignancy: a review of the United Network for Organ Sharing (UNOS) database.
    Austin MT, Leys CM, Feurer ID, Lovvorn HN, O'Neill JA, Pinson CW, Pietsch JB.
    J Pediatr Surg; 2006 Jan; 41(1):182-6. PubMed ID: 16410130
    [Abstract] [Full Text] [Related]

  • 6. [Liver transplantation for hepatocellular carcinoma: a report of 60 cases].
    Chen GH, Yang Y, Lu MQ, Cai CJ, He XS, Zhu XF, Xu C, Li H, Huang JF.
    Zhonghua Wai Ke Za Zhi; 2004 Apr 07; 42(7):413-6. PubMed ID: 15144669
    [Abstract] [Full Text] [Related]

  • 7. Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome.
    Graziadei IW, Sandmueller H, Waldenberger P, Koenigsrainer A, Nachbaur K, Jaschke W, Margreiter R, Vogel W.
    Liver Transpl; 2003 Jun 07; 9(6):557-63. PubMed ID: 12783395
    [Abstract] [Full Text] [Related]

  • 8. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C.
    Shimoda M, Ghobrial RM, Carmody IC, Anselmo DM, Farmer DG, Yersiz H, Chen P, Dawson S, Durazo F, Han S, Goldstein LI, Saab S, Hiatt J, Busuttil RW.
    Liver Transpl; 2004 Dec 07; 10(12):1478-86. PubMed ID: 15558585
    [Abstract] [Full Text] [Related]

  • 9. Liver transplantation at the Sun Yat-Sen University of Medical Sciences in China.
    Huang J, He X, Chen G, Zhu X, Lu M, Wang G, Fu Y, Yang Y, Guan X.
    Chin Med J (Engl); 2002 Apr 07; 115(4):543-8. PubMed ID: 12133294
    [Abstract] [Full Text] [Related]

  • 10. A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation.
    Yao FY, Hirose R, LaBerge JM, Davern TJ, Bass NM, Kerlan RK, Merriman R, Feng S, Freise CE, Ascher NL, Roberts JP.
    Liver Transpl; 2005 Dec 07; 11(12):1505-14. PubMed ID: 16315294
    [Abstract] [Full Text] [Related]

  • 11. Impact of UCSF criteria according to pre- and post-OLT tumor features: analysis of 479 patients listed for HCC with a short waiting time.
    Decaens T, Roudot-Thoraval F, Hadni-Bresson S, Meyer C, Gugenheim J, Durand F, Bernard PH, Boillot O, Sulpice L, Calmus Y, Hardwigsen J, Ducerf C, Pageaux GP, Dharancy S, Chazouilleres O, Cherqui D, Duvoux C.
    Liver Transpl; 2006 Dec 07; 12(12):1761-9. PubMed ID: 16964590
    [Abstract] [Full Text] [Related]

  • 12. Living-donor liver transplantation for hepatocellular carcinoma.
    Kawasaki S.
    Hepatogastroenterology; 2002 Dec 07; 49(43):53-5. PubMed ID: 11941984
    [Abstract] [Full Text] [Related]

  • 13. Effect of living donor liver transplantation on outcome of children with inherited liver disease and hepatocellular carcinoma.
    Ozçay F, Canan O, Bilezikçi B, Torgay A, Karakayali H, Haberal M.
    Clin Transplant; 2006 Dec 07; 20(6):776-82. PubMed ID: 17100729
    [Abstract] [Full Text] [Related]

  • 14. Liver transplantation for hepatocellular carcinoma in children.
    Sevmis S, Karakayali H, Ozçay F, Canan O, Bilezikci B, Torgay A, Haberal M.
    Pediatr Transplant; 2008 Feb 07; 12(1):52-6. PubMed ID: 18186889
    [Abstract] [Full Text] [Related]

  • 15. Living donor liver transplantation of the right lobe for hepatocellular carcinoma in cirrhosis in a European center.
    Jonas S, Mittler J, Pascher A, Schumacher G, Theruvath T, Benckert C, Rudolph B, Neuhaus P.
    Liver Transpl; 2007 Jun 07; 13(6):896-903. PubMed ID: 17538994
    [Abstract] [Full Text] [Related]

  • 16. Outcome of pediatric liver transplant recipients in Turkey: single center experience.
    Aydogdu S, Arikan C, Kilic M, Ozgenc F, Akman S, Unal F, Yagci RV, Tokat Y.
    Pediatr Transplant; 2005 Dec 07; 9(6):723-8. PubMed ID: 16269042
    [Abstract] [Full Text] [Related]

  • 17. Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantation.
    Tamura S, Kato T, Berho M, Misiakos EP, O'Brien C, Reddy KR, Nery JR, Burke GW, Schiff ER, Miller J, Tzakis AG.
    Arch Surg; 2001 Jan 07; 136(1):25-30; discussion 31. PubMed ID: 11146770
    [Abstract] [Full Text] [Related]

  • 18. Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation.
    Lu DS, Yu NC, Raman SS, Lassman C, Tong MJ, Britten C, Durazo F, Saab S, Han S, Finn R, Hiatt JR, Busuttil RW.
    Hepatology; 2005 May 07; 41(5):1130-7. PubMed ID: 15841454
    [Abstract] [Full Text] [Related]

  • 19. Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list.
    Yao FY, Bass NM, Nikolai B, Davern TJ, Kerlan R, Wu V, Ascher NL, Roberts JP.
    Liver Transpl; 2002 Oct 07; 8(10):873-83. PubMed ID: 12360427
    [Abstract] [Full Text] [Related]

  • 20. Liver transplantation for malignant diseases: selection and pattern of recurrence.
    Margarit C, Charco R, Hidalgo E, Allende H, Castells L, Bilbao I.
    World J Surg; 2002 Feb 07; 26(2):257-63. PubMed ID: 11865357
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 38.